First Time Loading...

Janux Therapeutics Inc
NASDAQ:JANX

Watchlist Manager
Janux Therapeutics Inc Logo
Janux Therapeutics Inc
NASDAQ:JANX
Watchlist
Price: 47.99 USD 1.89% Market Closed
Updated: May 21, 2024

EV/EBITDA
Enterprise Value to EBITDA

-25.9
Current
-4.1
Median
4.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-25.9
=
Enterprise Value
1.8B
/
EBITDA
-70.8m
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-17.9
2-Years Forward
EV/EBITDA
-15.3
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More